Northern Trust’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13M Sell
759,553
-10,264
-1% -$176K ﹤0.01% 1916
2025
Q1
$49.1M Sell
769,817
-33,694
-4% -$2.15M 0.01% 1093
2024
Q4
$97.7M Buy
803,511
+147,874
+23% +$18M 0.01% 727
2024
Q3
$81.9M Sell
655,637
-12,441
-2% -$1.55M 0.01% 751
2024
Q2
$106M Buy
668,078
+237,255
+55% +$37.5M 0.02% 614
2024
Q1
$55.8M Sell
430,823
-6,743
-2% -$873K 0.01% 911
2023
Q4
$42.2M Buy
437,566
+12,143
+3% +$1.17M 0.01% 1118
2023
Q3
$51.6M Buy
425,423
+14,868
+4% +$1.8M 0.01% 912
2023
Q2
$47M Buy
410,555
+10,136
+3% +$1.16M 0.01% 1015
2023
Q1
$55.2M Buy
400,419
+8,793
+2% +$1.21M 0.01% 890
2022
Q4
$50.7M Buy
391,626
+6,073
+2% +$787K 0.01% 918
2022
Q3
$42.6M Buy
385,553
+2,526
+0.7% +$279K 0.01% 949
2022
Q2
$28.7M Sell
383,027
-17,599
-4% -$1.32M 0.01% 1287
2022
Q1
$31.3M Sell
400,626
-5,545
-1% -$433K 0.01% 1363
2021
Q4
$36.6M Buy
406,171
+13,744
+4% +$1.24M 0.01% 1333
2021
Q3
$36.3M Buy
392,427
+4,217
+1% +$390K 0.01% 1340
2021
Q2
$30.2M Sell
388,210
-94,592
-20% -$7.35M 0.01% 1589
2021
Q1
$36M Sell
482,802
-7,995
-2% -$596K 0.01% 1391
2020
Q4
$83.7M Buy
490,797
+2,672
+0.5% +$456K 0.02% 722
2020
Q3
$68.5M Buy
488,125
+10,982
+2% +$1.54M 0.02% 729
2020
Q2
$76.5M Buy
477,143
+16,316
+4% +$2.62M 0.02% 631
2020
Q1
$45.1M Buy
460,827
+22,486
+5% +$2.2M 0.01% 833
2019
Q4
$56.6M Buy
438,341
+2,606
+0.6% +$336K 0.01% 931
2019
Q3
$32.8M Buy
435,735
+100,157
+30% +$7.54M 0.01% 1292
2019
Q2
$51M Buy
335,578
+22,903
+7% +$3.48M 0.01% 982
2019
Q1
$37.3M Sell
312,675
-5,612
-2% -$669K 0.01% 1205
2018
Q4
$34.7M Buy
318,287
+19,473
+7% +$2.13M 0.01% 1130
2018
Q3
$48.3M Buy
298,814
+627
+0.2% +$101K 0.01% 1057
2018
Q2
$39.4M Sell
298,187
-415,572
-58% -$54.9M 0.01% 1223
2018
Q1
$52.9M Sell
713,759
-413
-0.1% -$30.6K 0.01% 949
2017
Q4
$39.7M Buy
714,172
+3,530
+0.5% +$196K 0.01% 1169
2017
Q3
$32.2M Buy
710,642
+81,138
+13% +$3.68M 0.01% 1326
2017
Q2
$21.2M Buy
629,504
+20,680
+3% +$697K 0.01% 1626
2017
Q1
$18M Buy
608,824
+28,301
+5% +$838K 0.01% 1707
2016
Q4
$15.9M Buy
580,523
+72,956
+14% +$2M ﹤0.01% 1765
2016
Q3
$31.2M Buy
507,567
+2,930
+0.6% +$180K 0.01% 1217
2016
Q2
$9.62M Sell
504,637
-26,760
-5% -$510K ﹤0.01% 2051
2016
Q1
$10.4M Buy
531,397
+15,330
+3% +$299K ﹤0.01% 1954
2015
Q4
$19.9M Buy
516,067
+46,953
+10% +$1.81M 0.01% 1515
2015
Q3
$15.1M Buy
469,114
+11,048
+2% +$355K 0.01% 1699
2015
Q2
$13.9M Buy
458,066
+7,161
+2% +$218K ﹤0.01% 1845
2015
Q1
$5.99M Buy
450,905
+6,352
+1% +$84.4K ﹤0.01% 2397
2014
Q4
$6.43M Sell
444,553
-14,036
-3% -$203K ﹤0.01% 2336
2014
Q3
$9.68M Sell
458,589
-9,175
-2% -$194K ﹤0.01% 2066
2014
Q2
$13.9M Sell
467,764
-21,803
-4% -$650K ﹤0.01% 1802
2014
Q1
$11.8M Sell
489,567
-46,208
-9% -$1.11M ﹤0.01% 1983
2013
Q4
$10.9M Buy
535,775
+56,969
+12% +$1.16M ﹤0.01% 2032
2013
Q3
$22.6M Buy
478,806
+271,471
+131% +$12.8M 0.01% 1363
2013
Q2
$7.89M Buy
+207,335
New +$7.89M ﹤0.01% 2099